Cyren Balans Gezondheid

Financiële gezondheid criteriumcontroles 0/6

Onvoldoende gegevens om de gezondheid van Cyren te bepalen

Belangrijke informatie

n/a

Verhouding schuld/eigen vermogen

n/a

Schuld

Rente dekkingsratio	n/a
Contant	n/a
Aandelen	n/a
Totaal verplichtingen	n/a
Totaal activa	n/a

Recente financiële gezondheidsupdates

Is Cyren (NASDAQ:CYRN) Using Debt In A Risky Way?

Jun 13

We Think Cyren (NASDAQ:CYRN) Has A Fair Chunk Of Debt

Sep 02

Recent updates

Analyse van de financiële positie

Kortlopende schulden: Er zijn onvoldoende gegevens om te bepalen of de kortetermijnactiva van CYRN.Q de kortetermijnschulden dekken.

Langlopende schulden: Er zijn onvoldoende gegevens om te bepalen of de kortetermijnactiva van CYRN.Q de langetermijnschulden dekken.

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: Er zijn onvoldoende gegevens om de netto schuld/eigen vermogen ratio CYRN.Q te berekenen om te bepalen of deze voldoende is.

Schuld verminderen: Er zijn onvoldoende gegevens om te bepalen of de schuld/eigen vermogen-ratio van CYRN.Q de afgelopen 5 jaar is gedaald.

Schuldendekking: Er zijn onvoldoende gegevens om te bepalen of de schulden van CYRN.Q goed gedekt zijn door de operationele kasstroom.

Rentedekking: Er zijn onvoldoende gegevens om te bepalen of de rentebetalingen van CYRN.Q op haar schulden goed worden gedekt door EBIT.

Cyren Balans Gezondheid

Financiële gezondheid criteriumcontroles 0/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Cyren Files Form 15

Cyren Receives Written Notice from Nasdaq Regarding Minimum Closing Bid Requirement for Continued Listing on the Nasdaq Capital Market

Is Cyren (NASDAQ:CYRN) Using Debt In A Risky Way?

Cyren Regains Compliance with Nasdaq Listing Requirements

We Think Cyren (NASDAQ:CYRN) Has A Fair Chunk Of Debt

Recent updates

Cyren Files Form 15

Cyren Ltd. Announces Chief Financial Officer Changes

Cyren Receives Written Notice from Nasdaq Regarding Minimum Closing Bid Requirement for Continued Listing on the Nasdaq Capital Market

Insufficient new directors

Cyren Ltd. to Report Q3, 2022 Results on Nov 14, 2022

Cyren Launches Hybrid Analyzer for Unmatched Speed and Scale of Malware Analysis

Second quarter 2022 earnings released: US$0.75 loss per share (vs US$1.48 loss in 2Q 2021)

Cyren Ltd., Annual General Meeting, Aug 31, 2022

Cyren Ltd. to Report Q2, 2022 Results on Aug 15, 2022

Cyren Ltd. Appoints P. Brady Hayden as Principal Accounting Officer

Is Cyren (NASDAQ:CYRN) Using Debt In A Risky Way?

Content Services Group GmbH entered into a definitive Sale and Purchase Agreement to acquire Cyren GmbH from Cyren Ltd. (NasdaqCM:CYRN) for €10 million.

Cyren Ltd. Announces Retirement of Kenneth Tarpey, Principal Accounting Officer, Effective May 31, 2022

First quarter 2022 earnings released

Cyren Ltd. to Report Q1, 2022 Results on May 16, 2022

Insufficient new directors

Cyren - A Short Squeeze Could Present Short-Selling Opportunities

Cyren Regains Compliance with Nasdaq Listing Requirements

Cyren Ltd. announced that it has received $12.000003 million in funding

Third quarter 2021 earnings released: US$0.074 loss per share (vs US$0.081 loss in 3Q 2020)

We Think Cyren (NASDAQ:CYRN) Has A Fair Chunk Of Debt

Second quarter 2021 earnings released: US$0.074 loss per share (vs US$0.077 loss in 2Q 2020)

Independent Director Todd Thomson has left the company

First quarter 2021 earnings released: US$0.061 loss per share (vs US$0.046 loss in 1Q 2020)

Chief Technology Officer has left the company

Full year 2020 earnings released: US$0.29 loss per share (vs US$0.33 loss in FY 2019)

Price target decreased to US$1.50

CYREN Ltd. has completed a Follow-on Equity Offering in the amount of $13.8 million.

CYREN Ltd. to Report Q4, 2020 Results on Feb 22, 2021

Cyren Ltd. Announces CFO Changes

Cyren Ltd. Announces Resignation of Lior Samuelson as Member of the Board of Directors

CYREN Ltd. to Report Q3, 2020 Results on Nov 16, 2020

Commtouch Software Ltd. to Report Q1, 2010 Results on 05/04/2010

CYREN Ltd.(NasdaqCM:CYRN) dropped from Russell Microcap Growth Index

CYREN Ltd.(NasdaqCM:CYRN) dropped from Russell Microcap Index

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven